These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 11246546

  • 21. High prevalence of factor V Leiden in healthy Jordanian Arabs.
    Awidi A, Shannak M, Bseiso A, Kailani MA, Kailani MA, Omar N, Anshasi B, Sakarneh N.
    Thromb Haemost; 1999 Apr; 81(4):582-4. PubMed ID: 10235443
    [Abstract] [Full Text] [Related]

  • 22. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
    Coen D, Zadro R, Honović L, Banfić L, Stavljenić Rukavina A.
    Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
    [Abstract] [Full Text] [Related]

  • 23. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K, Larson G, Lindahl TL, Andersson C, Frison L, Gustafsson D, Bylock A, Eriksson BI.
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [Abstract] [Full Text] [Related]

  • 24. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL, Welsh CH, Qamar Z, Marlar RA.
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [Abstract] [Full Text] [Related]

  • 25. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM.
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [Abstract] [Full Text] [Related]

  • 26. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
    Rehak M, Rehak J, Müller M, Faude S, Faude F, Siegemund A, Krcova V, Slavik L, Hasenclever D, Scholz M, Wiedemann P.
    Thromb Haemost; 2008 May; 99(5):925-9. PubMed ID: 18449423
    [Abstract] [Full Text] [Related]

  • 27. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H, El-Koofy N, El-Hawary M, Mostafa A, Aziz M, El-Shabrawi M, Mohsen NA, Kotb M, El-Raziky M, El-Sonoon MA, A-Kader H.
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [Abstract] [Full Text] [Related]

  • 28. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, Heis N, Castaman G, Missiaglia E, Lechner K, Rodeghiero F.
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [Abstract] [Full Text] [Related]

  • 29. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
    Schöni R, Quehenberger P, Wu JR, Wilmer M.
    Thromb Res; 2007 Sep; 119(1):17-26. PubMed ID: 16934314
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems.
    Girolami A, Simioni P, Tormene D.
    Haematologica; 2000 Mar; 85(3):225-6. PubMed ID: 10702806
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Factor V Leiden mutation and type 1 diabetes mellitus.
    Demirer AN, Alikasifoglu M, Tuncbilek E, Karakus S, Erbas T.
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):70-4. PubMed ID: 18180619
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.
    Morange PE, Aillaud MF, Nicaud V, Henry M, Juhan-Vague I.
    Thromb Haemost; 2001 Dec; 86(6):1583-4. PubMed ID: 11776333
    [No Abstract] [Full Text] [Related]

  • 37. Activated protein C resistance in anterior ischaemic optic neuropathy.
    Nagy V, Facsko A, Takacs L, Balazs E, Berta A, Balogh I, Edes I, Czuriga I, Pfliegler G.
    Acta Ophthalmol Scand; 2004 Apr; 82(2):140-3. PubMed ID: 15043529
    [Abstract] [Full Text] [Related]

  • 38. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile.
    Margaglione M, Bossone A, Coalizzo D, D'Andrea G, Brancaccio V, Ciampa A, Grandone E, Di MG.
    Thromb Haemost; 2002 Jan; 87(1):32-6. PubMed ID: 11848454
    [Abstract] [Full Text] [Related]

  • 39. [Cerebral venous thrombosis and factor V Leiden mutation].
    Meng Q, Pu C.
    Zhonghua Yi Xue Za Zhi; 2002 Jan 10; 82(1):47-9. PubMed ID: 11953127
    [Abstract] [Full Text] [Related]

  • 40. Mesenteric vein thrombosis due to factor V Leiden gene mutation.
    Bergenfeldt M, Svensson PJ, Borgström A.
    Br J Surg; 1999 Aug 10; 86(8):1059-62. PubMed ID: 10460643
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.